This inventor holds 2 USPTO granted patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2002-2003.
Location History:
- Shiki, JP (2002)
- Saitama, JP (2003)
Company Filing History:
Years Active: 2002-2003
Title: Ryoichi Ishitani: Innovator in Motor Dysfunction Remedies
Introduction
Ryoichi Ishitani is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of medical science, particularly in developing remedies for motor dysfunction. With a total of 2 patents, his work focuses on innovative solutions to complex health issues.
Latest Patents
Ishitani's latest patents include an antibody against glyceraldehyde-3-phosphate dehydrogenase and its use in treating motor dysfunction. His second patent involves remedies for motor dysfunction and GAPDH expression inhibitors, specifically those containing N-[3-[N-(4-chlorophenylmethyl)carbamoyl]propanoyl]-L-prolinal as the active ingredient. This compound has shown promise in ameliorating motor dysfunction caused by various conditions such as trauma, infection, degeneration, ischemia, and tumors. Additionally, it is beneficial in treating diseases linked to apoptosis in the cerebellum and spinal nerve nucleus, including Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).
Career Highlights
Ryoichi Ishitani is currently employed at Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative therapeutic solutions.
Collaborations
Ishitani collaborates with fellow researcher Nobuo Katsube, contributing to the advancement of their shared goals in medical innovation.
Conclusion
Ryoichi Ishitani's contributions to the field of motor dysfunction remedies highlight his dedication to medical innovation. His patents reflect a deep understanding of complex health issues and a commitment to finding effective treatments.